P-Glycoprotein Expression, Tumor Weight, Age, and Relapse in Patients with Stage I and II Favorable-Histology Wilms` Tumor


Autoria(s): TEIXEIRA, Roberto Augusto Plaza; ODONE-FILHO, Vicente; CAMARGO, Beatriz de; ZERBINI, Maria Claudia; FILLIPI, Renne; ALENCAR, Arlaine; CRISTOFANI, Lilian
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2011

Resumo

Fifteen percent of patients with Wilms`` tumor (WT) experience relapse. It has been suggested that weight and age may affect the chances of relapse. Few studies have investigated the role, if any, between P-glycoprotein (P-gp) and relapse. The authors assessed the prognostic value of tumor weight and age at diagnosis and asked whether some other potential biological markers, specifically P-gp protein expression, had a prognostic value in favorable-histology WT. No association between age and relapse could be found. Patients with tumor weight >= a parts per thousand yen550 g were 6 times more likely to relapse, whereas P-gp expression was positive in 18/40 (45%%) of the patients, of which 10/12 (83.3%%) relapsed and 8/28 (28.6%%) did not. Further studies are necessary to elucidate whether or not P-gp is related to relapse in patients with histologically favorable Wilms`` tumor. If confirmed, the protein may be used in the future as a target for new drugs and treatments for this group of patients.</.

Identificador

PEDIATRIC HEMATOLOGY AND ONCOLOGY, v.28, n.3, p.194-202, 2011

0888-0018

http://producao.usp.br/handle/BDPI/30442

10.3109/08880018.2010.533250

http://dx.doi.org/10.3109/08880018.2010.533250

Idioma(s)

eng

Publicador

INFORMA HEALTHCARE

Relação

Pediatric Hematology and Oncology

Direitos

closedAccess

Copyright INFORMA HEALTHCARE

Palavras-Chave #P-glycoprotein #prognosis #recurrence #tumor weight #Wilms` tumor #MULTIDRUG-RESISTANCE #PROGNOSTIC-FACTORS #THERAPY #ANAPLASIA #CHILDREN #KIDNEY #2ND #Oncology #Hematology #Pediatrics
Tipo

article

original article

publishedVersion